The Enterprise Value as of December 2025 (TTM) for Starpharma Holdings Limited (SPHRY) is 152.19M

According to Starpharma Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 152.19M. This represents a change of 452.59% compared to the average of 27.54M of the last 4 quarters.

Starpharma Holdings Limited (SPHRY) Historical Enterprise Value (quarterly & annually)

How has SPHRY Enterprise Value performed in the past?

The mean historical Enterprise Value of Starpharma Holdings Limited over the last ten years is 252.46M. The current 152.19M Enterprise Value has changed 5.93% with respect to the historical average. Over the past ten years (40 quarters), SPHRY's Enterprise Value was at its highest in in the June 2021 quarter at 549.78M. The Enterprise Value was at its lowest in in the December 2005 quarter at 0.

Starpharma Holdings Limited (SPHRY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Starpharma Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Starpharma Holdings Limited (SPHRY) Average Enterprise Value

How has SPHRY Enterprise Value performed in the past?

The current Enterprise Value of Starpharma Holdings Limited (SPHRY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Starpharma Holdings Limited (SPHRY) Enterprise Value vs. Peers

How is SPHRY’s Enterprise Value compared to its peers?

Starpharma Holdings Limited’s Enterprise Value is greater than Imugene Limited (81.08M), greater than Satellos Bioscience Inc. (41.10M), greater than IXICO plc (5.88M), greater than Alterity Therapeutics Limited (48.31M), greater than Paradigm Biopharmaceuticals Limited (127.34M), greater than Poolbeg Pharma PLC (15.21M), greater than BioStem Technologies, Inc. (42.41M), greater than Nicox S.A. (31.80M), less than Kintor Pharmaceutical Limited (824.09M), greater than BioSyent Inc. (122.83M),

Build a custom stock screener for Starpharma Holdings Limited (SPHRY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Starpharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Starpharma Holdings Limited (SPHRY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Starpharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.